BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37190310)

  • 1. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes.
    Ornella MSC; Badrinath N; Kim KA; Kim JH; Cho E; Hwang TH; Kim JJ
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.
    Thadi A; Khalili M; Morano WF; Richard SD; Katz SC; Bowne WB
    Vaccines (Basel); 2018 Aug; 6(3):. PubMed ID: 30103457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
    Wei GX; Du Y; Zhou YW; Li LJ; Qiu M
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):851-861. PubMed ID: 36107723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.
    Goéré D; Gras-Chaput N; Aupérin A; Flament C; Mariette C; Glehen O; Zitvogel L; Elias D
    BMC Cancer; 2014 Mar; 14():148. PubMed ID: 24589307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal immunotherapy: historical perspectives and modern therapy.
    Morano WF; Aggarwal A; Love P; Richard SD; Esquivel J; Bowne WB
    Cancer Gene Ther; 2016 Nov; 23(11):373-381. PubMed ID: 27834358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of immunotherapy in peritoneal carcinomatosis.
    Ströhlein MA; Heiss MM; Jauch KW
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1019-27. PubMed ID: 27530056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.
    Katz SC; Point GR; Cunetta M; Thorn M; Guha P; Espat NJ; Boutros C; Hanna N; Junghans RP
    Cancer Gene Ther; 2016 May; 23(5):142-8. PubMed ID: 27080226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study.
    Qian S; Chen J; Zhao Y; Zhu X; Dai D; Qin L; Hong J; Xu Y; Yang Z; Li Y; Guijo I; Jiménez-Galanes S; Guadalajara H; García-Arranz M; García-Olmo D; Shen J; Villarejo-Campos P; Qian C
    Cytotherapy; 2024 Feb; 26(2):113-125. PubMed ID: 37999667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications.
    Qian S; Villarejo-Campos P; García-Olmo D
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
    de Boer NL; van Kooten JP; Burger JWA; Verhoef C; Aerts JGJV; Madsen EVE
    BMJ Open; 2019 May; 9(5):e026779. PubMed ID: 31092657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 12. The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis.
    Ströhlein MA; Heiss MM
    Future Oncol; 2010 Sep; 6(9):1387-94. PubMed ID: 20919824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
    Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer.
    Lee YS; Lee WS; Kim CW; Lee SJ; Yang H; Kong SJ; Ning J; Yang KM; Kang B; Kim WR; Chon HJ; Kim C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33199510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant tumors in children: Initial experience in a single institution.
    Zhu Z; Chang X; Wang J; Yang S; Qin H; Yang W; Cheng H; Meng D; Wang H
    Front Surg; 2022; 9():1078039. PubMed ID: 36713659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.
    Harper MM; Kim J; Pandalai PK
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.
    Mahmoud AM; Ismail YM; Hussien A; Debaky Y; Ahmed IS; Mikhael HSW; Moneer M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):143-150. PubMed ID: 30472198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases.
    Tonello M; Ortega-Perez G; Alonso-Casado O; Torres-Mesa P; Guiñez G; Gonzalez-Moreno S
    Clin Transl Oncol; 2018 Oct; 20(10):1268-1273. PubMed ID: 29667123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Freudenberger DC; Vudatha V; Riner AN; Herremans KM; Fernandez LJ; Trevino JG
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Curr Oncol; 2020 Jun; 27(3):146-154. PubMed ID: 32669924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.